Peptides for hair growth: what the evidence actually supports

What did @juliesoria.fnp actually say?

Here's the awkward truth: the transcript attached to this video is not a health claim at all. It appears to be song lyrics, not medical commentary. So we're working from the caption, which reads: "science-backed peptides can help tell your body how to repair, regenerate, and actually grow stronger, healthier hair." That's the claim on the table, and it's worth examining seriously regardless of what the audio actually contains.

The caption positions peptide therapy as a step beyond shampoos, supplements, and "Instagram hacks," framing it as an inside-out biological fix for slow, thin, or uncooperative hair. That framing is partially reasonable, but the phrase "science-backed" is doing a lot of heavy lifting here without a single citation to support it.

Does the science back this up?

Partially, and with significant caveats. The peptide with the strongest hair-related evidence is GHK-Cu (copper tripeptide-1). Research by Pickart and Margolina (2018, Biomedicines) found that GHK-Cu activates hair follicle stem cells and may extend the anagen (growth) phase. That's real, peer-reviewed work. However, most of this research is preclinical or in vitro, meaning it was done in labs, not in large human trials.

BPC-157, TB-500, and growth hormone secretagogues like CJC-1295 and ipamorelin have essentially no direct human clinical evidence for hair growth specifically. Studies on BPC-157 (Sikiric et al., 2018, Current Pharmaceutical Design) focus on wound healing and gut repair, not follicle regeneration. Extrapolating healing mechanisms to hair growth is a logical leap, not a proven pathway. The science is suggestive in places, not settled.

What did they get wrong (or right)?

They got the general direction right. Hair loss does have systemic biological drivers, including inflammation, oxidative stress, and declining growth factor signaling. Addressing those from the inside out is a legitimate therapeutic concept. Credit where it's due.

What's missing is precision. Saying peptides "tell your body how to repair and regenerate" is vague enough to mean almost anything. Which peptides? At what dose? Through what delivery mechanism? Topical GHK-Cu serums have a completely different evidence base than injectable BPC-157, and lumping them together as "science-backed" misleads people who are trying to make real decisions about real interventions.

• GHK-Cu has actual human-relevant data for hair follicle activation.
• BPC-157 and TB-500 do not have specific hair growth trials in humans.
• MK-677 raises IGF-1, which theoretically could support follicle activity, but no direct hair growth trials confirm this.
• Semax and selank have no meaningful hair-related research at all.

What should you actually know?

If you're losing hair and considering peptides, the conversation should start with a diagnosis. Androgenetic alopecia, telogen effluvium, thyroid dysfunction, and nutritional deficiencies all look similar and respond to different interventions. Jumping to peptide therapy without ruling those out is expensive and potentially distracting from treatments with much stronger evidence, like minoxidil or finasteride.

For GHK-Cu specifically, topical formulations have a reasonable safety profile and some supporting data. Maas et al. (2020, Journal of Cosmetic Dermatology) found improvements in hair density with topical copper peptide use over 12 weeks. That's a modest but real result. Injectable peptide protocols for hair growth remain largely in the experimental category and should only happen under proper clinical supervision with informed consent about limited evidence.

The "inside out" framing isn't wrong. It's just incomplete without telling people what "inside out" actually means in clinical practice.